Venture Fund Member Profile
|
 |
 |
The Connecticut Legislature created Connecticut Innovations (CI) in 1989 and charged it with growing Connecticut's entrepreneurial, technology economy by making venture and other investments. By building a vibrant technology community in the state, Connecticut Innovations creates substantial, long-term economic opportunity for Connecticut citizens. Since 1995, CI has become the state's leading investor in high technology, investing more than $133 million in Connecticut companies. CI's investments benefit all Connecticut residents by attracting and retaining innovative companies; creating high-paying jobs; and positioning the state to excel in the global, knowledge-driven economy.
 |
Matthew Smith Managing Director, Investments Connecticut Innovations |
Matthew B. Smith is Managing Director, Investments at Connecticut Innovations, Inc., a venture capital firm, and serves on the Board of Directors of several CI portfolio firms. Mr. Smith has a multifaceted range of healthcare experiences marked by leading edge business developments. His experiences include co-authoring the first federally funded HMO feasibility study and healthcare ventures with GTE New Ventures Corporation as well as other major medical firms, such as Technicon Corporation, American Hospital Supply Corporation and National Patent Development Corporation., where he rose to be the president of the Acme-Chaston subsidiary. Mr. Smith co-founded CompreMedx Cancer Centers Corporation (the first publicly traded firm to build freestanding cancer centers in partnership with oncologists and radiologists), co-owned Kramex Corporation (a privately owned portable and mobile radiology manufacturing and distribution firm), co-owned privately-held New World Healthcare Solutions, Inc. an executive recruiting and online medical education company for the healthcare industry and assisted in the turn around and sale of Medical Sterilization, Inc. (a publicly traded surgical instrumentation firm). In addition, he co-founded Health Excel Management, Inc. (a managed care firm specializing in disease state management) and turned around and sold venture backed HelpMate Robotics, Inc. (a publicly traded medical transport firm). He has served on the Board of Directors for Baseline Medical, Inc. and Campus Connects, Inc., and was Managing Director of Negin-Smith Partnership, a private real estate venture. Mr. Smith has served on the Board of Directors of selected non-profit organizations such as the Connecticut Venture Group (CVG), the Hamden (CT) Chamber of Commerce and the Long Ridge Club, Inc. Mr. Smith has been on the faculty of the Albert Einstein College of Medicine of Yeshiva University and Quinnipiac University School of Business and served as the first Executive Director of the Q.U. Entrepreneurship and Small Business Management Institute. He holds a BA in Psychology (1970) and an MBA with academic honors (1972) from Boston University.
Representative Investments
 |
Achillion Achillion is a product-focused pharmaceutical company committed to the discovery, development and commercialization of innovative anti-infective agents. Its emphasis is on antiviral drugs to treat infections caused by hepatitis B and C viruses, herpes viruses and the human immunodeficiency virus (HIV). |
 |
eNR Services, Inc. eNR Services, inc. delivers technology solutions and programs to aid professionals during every phase of the public relations and corporate communications cycle. Click on the links below for more information and to see for yourself why more than 1,000 companies, ranging from leading global brand names to emerging start-ups, log on to eNR’s integrated product set to build media lists, distribute press releases, and to monitor news coverage from print, broadcast and online media outlets in both domestic and international markets. |
 |
Nufern Nufern, located in East Granby, has a team of proven leaders in the manufacture and development of specialty fibers. Nufern’s unique approach to the development of fiber laser modules and optical fibers, from initial technical and design consultation to final delivery, enables our customers to develop new technologies and bring products to market without losing sight of their core competencies. |
 |
Proton Proton designs, develops and manufactures proton exchange membrane (PEM) electrochemical products. It uses these to produce HOGEN® hydrogen generators, which make high-quality hydrogen from water and electricity, and UNIGEN fuel cell systems, which have the potential to generate and store energy efficiently and cost-effectively. |
Matthew participated in the FundingPost event: VC Event: NYC Venture Capital Showcase
on Wednesday, Feb 11, 2009 in NY, Sponsored by Credit Suisse, Shelowitz & Associates, Hub International, Geller & Company
To list your Company on our website and make your profile available to Matthew and 7,500+ other VCs and Angel Investors, Click Here.
============================================
About FundingPost
For almost nine years FundingPost has worked with thousands
of Angel and Venture Capital Investors. We believe that it is
important to reach investors in every medium possible -
both online and offline. We have been directly responsible for
tons of success stories and Millions and Millions of dollars raised.
We look forward to introducing your company to the leading Venture and Angel Investors nationwide.
============================================
|
| Venture Fund Member Profile |
|